Member Info for Titania

https://ukinvestormagazine.co.uk/synairgen-shares-surge-on-commencement-of-coronavirus-treatment-trial/

Synairgen confirms commencement of dosing in trial of SNG001
https://www.synairgen.com/wp-content/uploads/2020/03/Commencement-of-dosing-in-COVID-19-trial-31-03-20.pdf

Synairgen confirms commencement of dosing in trial of SNG001
in COVID-19
Southampton, UK – 31 March 2020: Synairgen plc (LSE: SNG), the respiratory drug
discovery and development company, today announces that it has now commenced
dosing patients in its trial of SNG001 (inhaled formulation of interferon-beta-1a) in
COVID-19 patients. This announcement follows the one made by the Company on 18
March 2020.
The first patient has been dosed at the initial trial site (University Hospital Southampton
NHS Foundation Trust). Synairgen has initiated a further six trial sites which are
expected to start dosing in the coming days.
Richard Marsden, CEO of Synairgen, commented: “We are delighted to get this trial
underway with the dosing of the first patient. The team has worked tirelessly and
intensively with the relevant authorities and collaborators to get to this stage, and we
now look forward to recruiting more patients and completing the trial as soon as
possible. A successful outcome from this trial in COVID-19 patients would be a very
important step towards a major breakthrough in the fight against this coronavirus
pandemic.”

https://www.synairgen.com/wp-content/uploads/2020/03/Commencement-of-dosing-in-COVID-19-trial-31-03-20.pdf

Any sense of whether there are many investors who have bought the issue and sold the stock? A classic risk arb play but less so on Aim. These players would get burnt if the the vote goes down on waiving the preemption rights.